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ABSTRACT
Objective: Gold nanoparticles (AuNPs) can be used as targeted drug delivery systems, however, AuNPs have high surface energy and easily aggregate, 
thus negatively impacting nanoparticle stability. Therefore, it is necessary to add a stabilizing agent to AuNPs. To synthesize AuNPs stabilized by 
polyethylene glycol conjugated to folic acid (FA), thus creating a model drug (resveratrol [RSV]) carrier that targets FA receptors on cancer cells.
Methods: AuNPs were synthesized using the Turkevich method and stabilized by adding FA conjugated to polyethylene glycol (PEG). After RSV was 
loaded, the conjugate was physically characterized and subjected to stability tests.
Results: The RSV-AuNP had an average particle size of 51.97 nm (polydispersity index [PDI] 0.694, zeta potential – 24.6 mV). The RSV-AuNP-PEG-FA 
conjugate (RSV-AuNP-PEG-FA) had an average particle size of 195.6 nm (PDI=0.233, zeta potential=−21.1 mV). Stability tests showed that RSV-AuNP-
PEG-FA was more stable than RSV-AuNP. Furthermore, RSV-AuNP-PEG-FA and RSV-AuNP were more stable in buffer pH 7.4 and bovine serum albumin 
2% than in buffer pH 4, cysteine 1%, and NaCl 0.9% solutions.
Conclusion: PEG-FA conjugates can improve the stability of RSV-loaded AuNP.
Keywords: Polyethylene glycol, Folic acid, Gold nanoparticle, Resveratrol, Stability.
INTRODUCTION
Nanoparticles have several advantages, such as improvement in the 
intracellular infiltration, circulation time of the drug, and enhanced 
hydrophobic solubility [1]. They consist of different biodegradable 
materials such as natural or synthetic polymers, lipids, or metals [2]. 
Gold nanoparticles (AuNPs) are some of the most widely employed 
nanoparticles in medicine. AuNPs have been extensively applied 
in the fields of general drug delivery, targeted drug delivery, and 
disease diagnosis [3]. While AuNPs are very effective at targeted 
drug delivery, they have high surface energy and easily aggregate [4]. 
Stabilization of AuNPs can be accomplished by employing surfactants, 
by adding functional groups to the nanoparticle surface, or coating the 
nanoparticle with a polymer layer. One polymer that can be used as a 
stabilizing agent is polyethylene glycol (PEG). PEG can be used to coat 
nanoparticles, thus increasing nanoparticle stability and preventing 
nanoparticle aggregation [4]. PEGylation of nanoparticles can improve 
their in vivo stability, prevent surface attachment of opsonin proteins, 
and increase nanoparticle accumulation at tumor sites to increase 
antitumor activity [5].
Other important factors exist for increasing the cellular uptake process, 
such as nanoparticle surface modification with targeting moieties. 
Active targeting is a strategy, where functional targeting moieties are 
peripherally conjugated to the nanoparticle system, thus enabling 
the preferential accumulation of particles at the tumor site. In active 
targeting-based cancer treatments, common molecular targets include 
carbohydrates, antibodies, and cell surface receptors [6]. Folate 
receptors are present in many cancer cells [7], such as colon, lung, 
prostate, ovary, breast, and brain cancer cells [8]. Therefore, targeted 
treatment at folate receptors can be an effective option for cancer 
therapy. Nanoparticles conjugated with folic acid (FA) can selectively 
bind to cell surface folate receptors on cancerous cells and be 
internalized through endocytosis [6]. Since FA has a very high affinity 
for folate receptors, FA is a suitable ligand for targeted therapeutic 
receptors [9,10].
Resveratrol (RSV) (trans-3,4,5-trihydroxystilbene) is a naturally 
occurring polyphenol compound that possesses a variety of biological 
activities, such as anticancer and antioxidant activity [11-14]. Sun 
Young Park (2016) conducted a study employing RSV-conjugated 
AuNPs for breast cancer cell therapy and found that RSV acted as both a 
reducing agent and stabilizer for the AuNPs.
The purpose of this study was to synthesize a site-targeting drug 
delivery system using AuNPs stabilized by the addition of PEG and 
conjugated with FA-RSV which was used as a model drug compound, 




All materials were used as received: RSV standard (Sigma-Aldrich, USA), 
HAuCl4 (Sigma-Aldrich, USA), PEG-bis-amine (Sigma-Aldrich, USA), FA 
(Sigma-Aldrich, USA), sodium citrate (Sigma-Aldrich, USA), phosphate-
buffered saline (Sigma-Aldrich, USA), bovine serum albumin (BSA) 
(Sigma-Aldrich, USA), cysteine (Sigma-Aldrich, USA), sodium chloride 
(Merck, Germany), N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide 
(Sigma-Aldrich, USA), N-hydroxysuccinimide (Sigma-Aldrich, USA), 
hydrochloric acid (Merck, Germany), methanol (Merck, Germany), 
ethanol (Merck, Germany), acetonitrile (Merck, Germany), distilled 
water, and Aqua Bidest (Ika Pharmindo, Indonesia).
Methods
Synthesis of PEG-FA
FA (FA; 25 mg) was conjugated to PEG-bis-amine (250 mg; 1.5:1.0 molar 
ratio) in the presence of EDC (300 mg) and NHS (100 mg). The reaction 
Research Article
© 2020 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ijap.2020.v12s1.FF051
The 4th International Conference on Global Health 2019
Int J App Pharm, Vol 12, Special Issue 1, 2020
 Sutriyo et al. 
 The 4th International Conference on Global Health 2019 238
was accelerated by adding HCl (2% in water, 0.5 ml) and stirred for 5 h 
at room temperature. The reaction mixture was then centrifugated, and 
the top layer, containing FA conjugated to PEG (PEG-FA), was freeze-
dried to obtain the powder of PEG-FA conjugates.
Synthesis of the RSV-AuNP-PEG-FA conjugate (RSV-AuNP-PEG-FA)
AuNPs were synthesized according to the Turkevich method by 
reducing a hydrogen tetrachloroaurate solution using sodium citrate. 
A sodium citrate solution (0.705 mL and 130 mM) was added to a 
solution of HAuCl4·3H2O (25 mL and 1 mM) heated to approximately 
95°C with stirring. The color of the solution changed instantly from 
pale yellow to colorless. Then, the solution changed to dark blue and 
then to a deep red burgundy after a few minutes. Stirring and heating 
of the solution were maintained for several minutes after the addition 
of sodium citrate, and the solution was stirred during cooling at room 
temperature. PEG-FA (250 mg) was added to the above AuNP (25 ml) 
solution. The mixture was stirred at room temperature for 4 h to obtain 
AuNP-PEG-FA. Unreacted PEG-FA was removed by centrifugation. RSV 
solution (5.7 mL, 10 μg/mL) was added drop by drop to the continuously 
stirred AuNP-PEG-FA solution (150 rpm for 2 h at room temperature) to 
obtain RSV-AuNP-PEG-FA.
Synthesis of RSV-AuNP conjugates without stabilizer (RSV-AuNP)
AuNPs were synthesized according to the Turkevich method by 
reducing a hydrogen tetrachloroaurate solution using sodium citrate 
as above. RSV solution (5.7 mL, 10 μg/mL) was added drop by drop 
to the continuously stirred AuNP solution (150 rpm for 2 h at room 
temperature) to obtain RSV-AuNP.
Characterization of RSV-AuNP and RSV-AuNP-PEG-FA
General observations of RSV-AuNP and RSV-AuNP-PEG-FA
Observations of RSV-AuNP and RSV-AuNP-PEG-FA were recorded 
qualitatively from visual inspection of the conjugates.
Absorbance and wavelength measurements
The absorbance and wavelength measurements of RSV-AuNP-PEG-FA 
were performed using an ultraviolet (UV)-1800 spectrophotometer 
(Shimadzu, Japan) in the wavelength range of 400–800 nm.
Infrared spectrum analysis
The Fourier-transform infrared (FTIR) spectra (KBr pellet) of RSV, 
PEG-FA, AuNP, RSV-AuNP, and RSV-AuNP-PEG-FA were recorded on 
FTIR-8400S spectrometer (Shimadzu, Japan) in a wavenumber region 
of 400–4000 cm−1.
Particle size and size distribution measurements
The average particle size (z-average) and polydispersity index (PDI) of 
RSV-AuNP and RSV-AuNP-PEG-FA were determined through dynamic 
light scattering (DLS) at 25°C using a Malvern Zetasizer (Nano ZS, 
Malvern Instruments, Worcestershire, UK).
Zeta potential measurements
The zeta potential of RSV-AuNP and RSV-AuNP-PEG-FA was measured 
using a Malvern Zetasizer at 25°C (Nano ZS, Malvern Instruments, 
Worcestershire, UK).
Determination of RSV entrapment efficiency (%EE)
A 1000 ppm RSV solution in methanol (1 mg/mL) was serially diluted 
(1, 5, 10, 15, 20, and 25 ppm) to obtain a calibration curve. RSV-AuNP-
PEG-FA solution (2 mL) was ultracentrifuged (12,000 rpm at 27°C) 
for 1 h, and the supernatant was syringe filtered (0.22 µm pore size 
filter) and analyzed by HPLC. The amount of RSV trapped in the RSV-
AuNP-PEG-FA was determined indirectly using HPLC by subtracting 
the quantity in the supernatant from the total amount added. These 
analyses were performed in triplicate. The %EE of RSV was calculated 








Stability test of RSV-AuNP and RSV-AuNP-PEG-FA
The stability test of RSV-AuNP and RSV-AuNP-PEG-FA was performed 
using 4 mL of each sample equally aliquoted into 2 mL each of 
buffer pH 4, buffer pH 7.4, BSA 2%, cysteine 1%, and NaCl 0.9%. The 
physical appearance (aggregation), absorbance, changes in maximum 
absorbance wavelength, and changes in the full width at half maximum 
value were evaluated over 4 weeks. In the 1st week, evaluations were 
performed daily. Thereafter, evaluations were performed every 3 days.
RESULTS AND DISCUSSION
Synthesis of RSV-AuNP-PEG-FA
A brief optimization of the reaction time for AuNP synthesis after the 
addition of sodium citrate was performed (Table 1). As shown, an 
increase in absorbance was observed from 5 to 15 min. However, when 
the reaction time was increased to 25 min, the absorbance decreased 
to 0.305. The decrease in absorbance indicated aggregate formation. 
Therefore, 15 min of heating and stirring after sodium citrate addition 
was deemed optimal, as was also reported in the literature [15,16].
Characterization of RSV-AuNP and RSV-AuNP-PEG-FA
General observations of RSV-AuNP and RSV-AuNP-PEG-FA
The RSV-AuNP-PEG-FA solution was observed to have a red burgundy 
color. A red burgundy solution is characteristic of non-aggregated 
nanoparticles due to a rather narrow absorption wavelength at 520 nm. 
When the solution becomes blue, a AuNP solution is indicated to be 
partially aggregated [17]. The RSV-AuNP-PEG-FA has a clearer red 
burgundy color than RSV-AuNP. The RSV-AuNP-PEG-FA has a relatively 
stable red burgundy color after 7 days, while the RSV-AuNP became 
more purple by the 3rd day. Thus, the PEG coating was observed to 
improve nanoparticle stability to prevent AuNP aggregation [4].
Absorbance and wavelength measurements
Fig. 1 presents the UV-visible absorbance spectra of PEG-FA (0.256 at 
345.40 nm and 1.065 at 280.80 nm), AuNP (0.404 at 528 nm), RSV-
AuNP (0.260 at 529 nm), and RSV-AuNP-PEG-FA (0.890 at 533 nm 
and 1.989 at 279 nm). As shown in Fig. 1, the RSV-AuNP-PEG-FA curve 
was sharper than RSV-AuNP. According to Turkevich, the increase in 
particle size can result in a marked change in the width of spectral. It 
is possible that the particle size of RSV-AuNP-PEG-FA was smaller than 
that of RSV-AuNP. Moreover, in RSV-AuNP, there was no absorbance at 
279 nm, whereas in RSV-AuNP-PEG-FA, there was an absorbance at 
279 nm, indicative of a successful conjugation between PEG-FA and 
AuNP.
Table 1: Optimization of reaction time after sodium citrate 
addition
No. Duration of stirring 
and warming (min)
λ (nm) Absorbance
1. 5 528.00 0.404
2. 15 528.50 0.480
3. 25 538.50 0.305
Table 2: Selected parameters for RSV-AuNP and 
RSV-AuNP-PEG-FA
RSV-AuNP RSV-AuNP-PEG-FA
Particle size (nm) 51.97 195.6
PDI 0.694 0.233
Zeta potential (mV) −24.6 −21.1
AuNP: Gold nanoparticle, RSV: Resveratrol, PDI: Polydispersity, FA: Folic acid, 
PEG: Polyethylene glycol
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Infrared spectrum analysis
Fig. 2 presents the FTIR spectra of RSV, PEG-FA, AuNP, RSV-AuNP, and 
RSV-AuNP-PEG-FA. The characteristic peaks of RSV-AuNP-PEG-FA are 
3444.96 and 3284.88 cm−1 (OH), 1728.28 cm−1 (C=O), 1647.26 cm−1 
(C=C), 1546.96 and 1512.24 cm−1 (C=C aromatic), and 2357.09 cm−1. 
The same functional groups present on PEG-FA and RSV-AuNP-PEG-FA, 
such as O-H, C=O, and C=C, indicated that PEG-FA could be found on 
RSV-AuNP-PEG-FA. The peak intensity at 2357.09 cm−1 in RSV-AuNP-
PEG-FA was stronger than that of PEG-FA, AuNP, and RSV-AuNP because 
the PEG-FA and AuNP bond add to this peak. In contrast, the peak 
intensity of RSV at 833.28 cm−1 (para-substituted) disappeared in RSV-
AuNP-PEG-FA, indicative of RSV being absorbed into the AuNP.
Particle size and size distribution measurements
The particle size, particle size distribution, and PDI values of RSV-
AuNP-PEG-FA were obtained using a particle size analyzer with the 
DLS method. The DLS inner diameter is a value that refers to how the 
particle diffuses in a liquid and is referred to as the hydrodynamic 
diameter. This diameter is the spherical diameter and has the same 
translation diffusion coefficient as the particle [18]. The translation 
diffusion coefficient depends not only on the core particle size but also 
on each surface structure [19]. The average particle size formed from 
RSV-AuNP-PEG-FA was 195.6 nm, while that of RSV-AuNP was 51.97 nm. 
This difference in size results from PEG coating the surface of the AuNP. 
The particle-size distribution values based on the volume of the RSV-
AuNP-PEG-FA show that as many as 10% of the particles formed were 
<19.0 nm, 50% of the particles formed were <26.4 nm, and 90% of the 
particles formed were <88.1 nm. PDI is a value to determine the particle-
size distribution and ranges from 0 to 1. If the PDI value is <0.7, then 
the system is considered monodispersed. However, if the PDI value is 
>0.7, then the system is considered polydisperse [20]. The PDI value of 
RSV-AuNP-PEG-FA was 0.233; therefore, this is a monodispersed system.
Zeta potential measurements
The zeta potential of RSV-AuNP-PEG-FA was −21.1 mV, while that 
of RSV-AuNP was −24.6 mV. According to the American Filtration 
and Separations Society, RSV-AuNP-PEG-FA belongs within the “fine 
dispersion threshold.” The zeta potential value of RSV-AuNP-PEG-
FA was smaller than that of RSV-AuNP. This can be attributed to 
PEGylation. PEGylation is known to reduce the zeta potential value 
in accordance with the theory of steric stability in nanoparticles [8]. 
By surrounding the metal center with a steric material, a repulsive 
force is created between the metal nanoparticles [21]. Table 2 shows 
the comparison of RSV-AuNPs conjugate parameters with RSV-AuNPs-
PEG-FA conjugates.
Determination of RSV%EE
The calibration curve equation was y=92620 x–28703 with a 
correlation coefficient value r=0.997. The retention time of the RSV 
in RSV-AuNP-PEG-FA was 15.181 min, while in the standard solution, 
this was 15.396 min. The amount of RSV trapped in the nanoparticles 
(analysis in triplicate) was 57.67% (average of 57.74%, 57.36%, and 
57.90%). These results show that RSV was entrapped in RSV-AuNP-
PEG-FA.
Stability tests of RSV-AuNP and RSV-AuNP-PEG-FA
The results of the stability test showed that RSV-AuNP-PEG-FA was more 
stable than RSV-AuNP (Fig. 3). This was expected as PEG can improve 
the stability of nanoparticles according to the steric stability theory 
(shear dispersion around the metal center by steric materials) [21]. In 
buffer pH 4, both RSV-AuNP and RSV-AuNP-PEG-FA were not stable 
because changes in pH change can cause AuNPs to be aggregate. The 
acidic pH four buffer medium was intended to simulate the condition of 
cancer cells. In the RSV-AuNP-PEG-FA drug delivery system, FA would 
interact with folate receptors expressed on the cancer cell surface. After 
endocytosis of the nanoparticle into an acidic environment, the model 
drug (RSV) could be released from nanoparticle destabilizations. In 
medium buffer pH 7.4 and BSA 2%, both RSV-AuNP and RSV-AuNP-PEG-
FA were stable. Buffer pH 7.4 has an osmolarity and ion concentration 
isotonic or equivalent to the condition of human body fluids, and BSA 
2% simulated protein in plasma (human plasma can contain up to 60% 
total protein). Stability in these media suggests that the nanoparticle 
Fig. 1: Ultraviolet-visible spectra of polyethylene glycol (PEG)-bis-amine (a), resveratrol (RSV) (b), folic acid (FA) (c), PEG-FA (d), gold 
nanoparticle (AuNP) (e), RSV-AuNP (f), and RSV-AuNP-PEG-FA (g)
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Fig. 2: Fourier-transform infrared spectra of resveratrol (RSV) (purple), polyethylene glycol (PEG)-folic acid (FA) (green), gold 
nanoparticle (AuNP) (blue), RSV-AuNP (red), and RSV-AuNP-PEG-FA (black)
drug delivery system could stay intact in human plasma for several 
weeks and extend the drug release period. In cysteine 1% and NaCl 
0.9%, both RSV-AuNP and RSV-AuNP-PEG-FA were not stable (Fig. 3). 
The thiol groups in cysteine 1% interact with the gold and cause 
nanoparticle aggregation after breaking through the PEG coat. In NaCl 
0.9%, the PEG coat could not protect against the presence of additional 
electrolytes (cations and anions); moreover, aggregation to larger 
particles was observed [22].
Fig. 3: Stability tests of resveratrol (RSV)-gold nanoparticle (AuNP) and RSV-AuNP-polyethylene glycol-folic acid based on absorbance in 
(a) without medium, (b) buffer pH 4, (c) buffer pH 7.4, (d) bovine serum albumin 2%, (e) cysteine 1%, and (f) NaCl 0.9%
a cb
d e f
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CONCLUSION
RSV-AuNP-PEG-FA was successfully synthesized. The resulting particle 
solution was red burgundy in color and the average particle size was 
195.6 nm (PDI=0.233, zeta potential=−21.1 mV). The %EE of RSV in 
RSV-AuNP-PEG-FA was 57.67%. Stability tests showed that RSV-AuNP-
PEG-FA was more stable than RSV-AuNP and the stability of RSV-AuNP-
PEG-FA and RSV-AuNP in buffer pH 7.4 and BSA 2% was better than 
that in buffer pH 4, cysteine 1%, and NaCl 0.9%. From this research, 
we can conclude that the stabilization imparted by PEG-FA to AuNPs 
can improve the overall stability of the RSV-AuNP drug delivery system.
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